Literature DB >> 9347221

Aspects of Toxocara epidemiology: human toxocarosis.

P A Overgaauw1.   

Abstract

Toxocarosis is the clinical disease in man caused by infection of zoonotic roundworms of dogs and cats, Toxocara canis and T. cati. In this review the mode of transmission to the human by oral ingestion of Toxocara eggs from the environment is discussed. T. cati seems to play a more important role than generally suggested. Direct contact with animals is not considered a potential risk because embryonation of excreted Toxocara ova requires a minimum of 2 weeks. For the same reason there is no relationship expected between infection and exposure to dogs and cats in the household. Children more frequently have clinical symptoms because of the closer contact with contaminated soil in yards and sandpits, the lack of hygiene, and because of eating dirt. Toxocara larval migration in the body can cause various clinical syndromes. Visceral larva migrans, ocular larva migrans, and covert toxocarosis are described. Serodiagnostic techniques are reliable tools to detect antibodies or antigens. Systemic treatment with anthelmintics is described but can result in hypersensitivity reactions caused by dying larvae. For ocular lesions, laser photocoagulation and corticosteroid therapy are described. Preventive measures consist of preventing contamination of the environment with Toxocara eggs and for education of pet owners and non-pet owners to increase awareness about potential zoonotic hazards. Veterinary practitioners, general practitioners, and public health agencies should therefore provide sufficient information and advice.

Entities:  

Mesh:

Year:  1997        PMID: 9347221     DOI: 10.3109/10408419709115137

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  32 in total

1.  Environmental and serological evidence for the presence of toxocariasis in the urban area of Ancona, Italy.

Authors:  A Giacometti; O Cirioni; M Fortuna; P Osimani; L Antonicelli; M S Del Prete; A Riva; M M D'Errico; E Petrelli; G Scalise
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Toxocara canis meningomyelitis.

Authors:  Valérie Dauriac-Le Masson; Florence Chochon; Sophie Demeret; Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2005-10-05       Impact factor: 4.849

3.  Seroprevalence of human toxocariasis in Denmark.

Authors:  Christen R Stensvold; Jakob Skov; Lone N Møller; Per M Jensen; Christian M O Kapel; Eskild Petersen; Henrik V Nielsen
Journal:  Clin Vaccine Immunol       Date:  2009-07-29

4.  Production of Toxocara cati TES-120 Recombinant Antigen and Comparison with its T. canis Homolog for Serodiagnosis of Toxocariasis.

Authors:  Farzaneh Zahabiun; Seyed Mahmoud Sadjjadi; Muhammad Hafiznur Yunus; Anizah Rahumatullah; Mohammad Hosein Falaki Moghaddam; Syazwan Saidin; Rahmah Noordin
Journal:  Am J Trop Med Hyg       Date:  2015-06-01       Impact factor: 2.345

5.  Concomitant infestation of Toxocara cati and Ancylostoma tubaeforme in a mongrel cat.

Authors:  M Saravanan; K Sarma; D B Mondal; M Ranjith Kumar; H Vijayakumar
Journal:  J Parasit Dis       Date:  2014-03-11

Review 6.  Neuroparasitic infections: nematodes.

Authors:  M D Walker; J R Zunt
Journal:  Semin Neurol       Date:  2005-09       Impact factor: 3.420

Review 7.  Role of helminths in regulating mucosal inflammation.

Authors:  Joel V Weinstock; Robert W Summers; David E Elliott
Journal:  Springer Semin Immunopathol       Date:  2005-06-15

8.  Toxocara and Ascaris seropositivity among patients suspected of visceral and ocular larva migrans in the Netherlands: trends from 1998 to 2009.

Authors:  E Pinelli; T Herremans; M G Harms; D Hoek; L M Kortbeek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-02       Impact factor: 3.267

9.  Meningitis by Toxocara canis after ingestion of raw ostrich liver.

Authors:  Young Noh; Sung-Tae Hong; Ji Young Yun; Hong-Kyun Park; Jung-Hwan Oh; Young Eun Kim; Beom S Jeon
Journal:  J Korean Med Sci       Date:  2012-08-22       Impact factor: 2.153

10.  Treatment and prevention of vertical transmission of Toxocara cati in cats with an emodepside/praziquantel spot-on formulation.

Authors:  Sonja Wolken; Roland Schaper; Norbert Mencke; Friederike Kraemer; Thomas Schnieder
Journal:  Parasitol Res       Date:  2009-08       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.